Market reach growth Somanetics INVOS systems are already deployed in 700+ U.S. hospitals and 1,200+ international installations, indicating a scalable platform with established clinical familiarity and potential for expansion into non-U.S. markets and adjacent care settings.

Pediatric & brain focus With leadership in cerebral and somatic oximetry including adult and pediatric cerebral oximeters, there is a clear opportunity to upsell enhanced monitoring bundles for high-risk pediatric cardiac surgery programs and neurocritical care.

Clinical efficiency The noninvasive, continuous blood oxygen monitoring helps clinicians detect and correct compromised blood flow, presenting a value proposition for hospitals aiming to reduce complications, length of stay, and readmissions in at-risk patient cohorts.

Adjacent product synergy Recent ACTILINK and SOMANET initiatives suggest capability and interest in integrating motion control and automation solutions, offering cross-sell potential to manufacturers and OEMs seeking integrated monitoring with automated platforms.

Growth opportunities Current revenue range indicates a small to mid-market footprint with room to scale; potential in expanding installation networks, increasing number of elective high-volume centers, and pursuing strategic partnerships with major medical device portfolios.